NextPoint Therapeutics, Inc.

0 followers


NextPoint Therapeutics develops medications to expand the benefit of immunotherapies to cancer patients. The company offers immunotherapies for a validated checkpoint axis that is independent of PD-1/L1 and modulates both adaptive and innate immune systems to find and destroy cancer cells.

Industries

+2

Headquarters

Stage

Employees

Links

Org chart

Paul Conrad
Chief Business Officer, Corporate Secretary/treasurer

Paul Conrad

Collapse
Michael O'Meara
Vice President, Clinical Development Operations
Bijan Etemad-Gilbertson
Vice President, Antibody Technology
Stephanie D.
Director Technical Operations CMC